Family Office Of America (FOFA) Change in Accured Expenses (2021 - 2026)
Family Office Of America (FOFA) reported Change in Accured Expenses of -$73710.0 for Q1 2026, down 1462.73% on a YoY basis from $5409.0 in Q1 2025, and down 793.74% sequentially from $10625.0 in Q3 2025.
Family Office Of America (FOFA) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Family Office Of America (FOFA) has 6 years of Change in Accured Expenses data on file, last reported at -$73710.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses fell 1462.73% year-over-year to -$73710.0; the trailing twelve-month figure through Mar 2026 stood at -$78591.0 (down 532.58% YoY), and the FY2025 full-year result was $528.0, down 96.9% from the prior year.
- Change in Accured Expenses retreated to -$73710.0 in Q1 2026, from $10625.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $11052.0 in Q3 2024 to a low of -$73710.0 in Q1 2026.
- A 5-year average of -$8427.2 and a median of -$2361.0 in 2024 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses surged 182.69% in 2024 and plunged 1462.73% in 2026, its largest moves.
- Tracing FOFA's Change in Accured Expenses over 5 years: stood at -$14689.0 in 2022, then increased by 26.22% to -$10838.0 in 2023, then soared by 137.53% to $4068.0 in 2024, then soared by 161.18% to $10625.0 in 2025, then tumbled by 793.74% to -$73710.0 in 2026.
- Business Quant data shows FOFA's Change in Accured Expenses at -$73710.0 in Q1 2026, $10625.0 in Q3 2025, and -$15506.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Family Office Of America | 27.22 Mn | 26.88 Mn | 783,126.00 | -73,710.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73,710.00 |
| Mar 31, 2026 | -73,710.00 |
| Sep 30, 2025 | 10,625.00 |
| Sep 30, 2025 | 10,625.00 |
| Jun 30, 2025 | -15,506.00 |
| Jun 30, 2025 | -15,506.00 |
| Mar 31, 2025 | 5,409.00 |
| Mar 31, 2025 | 5,409.00 |
| Dec 31, 2024 | 4,068.00 |
| Dec 31, 2024 | 4,068.00 |
| Sep 30, 2024 | 11,052.00 |
| Sep 30, 2024 | 11,052.00 |
| Jun 30, 2024 | -2,361.00 |
| Jun 30, 2024 | -2,361.00 |
| Mar 31, 2024 | 4,300.00 |
| Mar 31, 2024 | 4,300.00 |
| Dec 31, 2023 | -10,838.00 |
| Dec 31, 2023 | -10,838.00 |
| Sep 30, 2023 | -13,366.00 |
| Sep 30, 2023 | -13,366.00 |